Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Capital Expenditures (2024 - 2025)

Hinge Health's Capital Expenditures history spans 2 years, with the latest figure at -$2.7 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 1815.29% year-over-year to -$2.7 million; the TTM value through Dec 2025 reached $1.1 million, changed N/A, while the annual FY2025 figure was $708000.0, 31.86% down from the prior year.
  • Capital Expenditures for Q4 2025 was -$2.7 million at Hinge Health, down from $3.2 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $3.2 million in Q3 2025 and bottomed at -$2.7 million in Q4 2025.